...
首页> 外文期刊>The Journal of Urology >Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
【24h】

Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.

机译:抢救性根治性前列腺切除术:生活质量和放射复发性前列腺癌的长期肿瘤控制。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: We review our 20-year experience with salvage radical prostatectomy to determine prognostic variables predictive of oncological control of radiorecurrent prostate cancer. Using a standardized questionnaire we also evaluate outcome data regarding the long-term sexual and urinary effects of salvage radical prostatectomy. MATERIALS AND METHODS: Between 1983 and 2002 salvage radical prostatectomy was performed in 51 patients with locally recurrent prostate cancer following definitive radiotherapy. Clinical information was obtained from a prospective database. Quality of life data were collected using the UCLA Prostate Cancer Index, a validated, patient administered instrument. RESULTS: At 5 years 47% of patients were progression-free without androgen deprivation therapy. Among patients with pT2 disease 100% were progression-free at 5 years, compared with 35% of patients with pT3N0 disease or higher and 0% of patients with node positive (pTxN+) disease (p < 0.001). Preoperative PSA 5.0 ng/ml or less was predictive of organ confined disease, and strongly associated with prolonged progression-free and overall survival (p < 0.001 and 0.01, respectively). Mean urinary function scores for patients with or without an artificial urinary sphincter compared favorably with scores reported after standard, nonsalvage prostatectomy. Sexual dysfunction was nearly uniform in patients undergoing standard salvage radical prostatectomy but implantation of a penile prosthesis was associated with a clinically significant improvement in sexual function. CONCLUSIONS: When initiated early in the course of recurrent disease, salvage radical prostatectomy provides excellent oncological control of radiorecurrent prostate cancer without the need for androgen ablation. Implantation of an artificial urinary sphincter and inflatable penile prosthesis devices in patients with postoperative urinary incontinence or erectile dysfunction results in significantly improved quality of life parameters.
机译:目的:我们回顾我们在挽救性前列腺癌的20年经验,以确定可预测放射性复发性前列腺癌的肿瘤控制的预后变量。使用标准化问卷,我们还评估了关于挽救前列腺癌根治术的长期性和泌尿作用的结局数据。材料与方法:在1983年至2002年之间,对51例经明确放疗后局部复发的前列腺癌患者进行了根治性前列腺切除术。从前瞻性数据库获得临床信息。使用UCLA前列腺癌指数(一种经过验证的患者管理工具)收集生活质量数据。结果:5年时,无雄激素剥夺治疗的患者中47%无进展。在患有pT2疾病的患者中,100%的患者在5年内无进展,而患有pT3N0或更高水平的患者为35%,淋巴结阳性(pTxN +)患者为0%(p <0.001)。术前PSA 5.0 ng / ml或更低可预测器官受限疾病,并与无进展生存期和总生存期密切相关(分别为p <0.001和0.01)。有或没有人工尿道括约肌的患者的平均尿功能评分与标准非抢救性前列腺切除术后报告的评分相比有优势。在进行标准抢救性前列腺癌根治术的患者中,性功能障碍几乎是一致的,但阴茎假体的植入与性功能的临床显着改善有关。结论:抢救性根治性前列腺切除术在疾病复发的早期进行,可提供对放射性复发性前列腺癌的出色肿瘤控制,而无需雄激素消融。在术后尿失禁或勃起功能障碍的患者中植入人工导尿括约肌和可充气的阴茎假体装置可显着改善生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号